JPH09505024A - 治療剤 - Google Patents

治療剤

Info

Publication number
JPH09505024A
JPH09505024A JP6522513A JP52251394A JPH09505024A JP H09505024 A JPH09505024 A JP H09505024A JP 6522513 A JP6522513 A JP 6522513A JP 52251394 A JP52251394 A JP 52251394A JP H09505024 A JPH09505024 A JP H09505024A
Authority
JP
Japan
Prior art keywords
pain
extract
ethanol
weeks
solvent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP6522513A
Other languages
English (en)
Japanese (ja)
Inventor
ダウンター，ブライアン
Original Assignee
メイン、キャンプ、マーケッティング、プロプライエタリ、リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by メイン、キャンプ、マーケッティング、プロプライエタリ、リミテッド filed Critical メイン、キャンプ、マーケッティング、プロプライエタリ、リミテッド
Publication of JPH09505024A publication Critical patent/JPH09505024A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Indole Compounds (AREA)
JP6522513A 1993-06-25 1994-06-24 治療剤 Pending JPH09505024A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU9605 1983-05-30
AUPL960593 1993-06-25
PCT/AU1994/000342 WO1995000157A1 (en) 1993-06-25 1994-06-24 Therapeutic agent

Publications (1)

Publication Number Publication Date
JPH09505024A true JPH09505024A (ja) 1997-05-20

Family

ID=3777003

Family Applications (1)

Application Number Title Priority Date Filing Date
JP6522513A Pending JPH09505024A (ja) 1993-06-25 1994-06-24 治療剤

Country Status (12)

Country Link
EP (1) EP0708651B1 (https=)
JP (1) JPH09505024A (https=)
CN (1) CN1129908A (https=)
AT (1) ATE185698T1 (https=)
CA (1) CA2165794A1 (https=)
DE (1) DE69421280T2 (https=)
ES (1) ES2140541T3 (https=)
IN (1) IN178310B (https=)
NZ (1) NZ267567A (https=)
PL (1) PL176595B1 (https=)
WO (1) WO1995000157A1 (https=)
ZA (1) ZA944568B (https=)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006528666A (ja) * 2003-05-14 2006-12-21 ディーエスエム アイピー アセッツ ビー．ブイ． 糖尿病の治療及び予防のためのフタリド誘導体の使用
JP2011256121A (ja) * 2010-06-07 2011-12-22 Kao Corp 電位依存性カチオンチャネル抑制剤
WO2021221456A1 (ko) * 2020-04-29 2021-11-04 한국 한의학 연구원 시라 추출물을 유효성분으로 함유하는 골질환의 예방, 개선 또는 치료용 조성물

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9821670D0 (en) * 1998-10-05 1998-12-02 Muhlbauer Roman C Plant extracts for the treatment of increased bone resorption
AUPP797598A0 (en) * 1998-12-30 1999-01-28 Butters, Desley Therapeutic agent
US6352728B1 (en) * 1999-11-02 2002-03-05 International Celery Development Alliance Pty. Ltd. Extracts of celery seed for the prevention and treatment of pain, inflammation and gastrointestinal irritation
GB0211943D0 (en) * 2002-05-23 2002-07-03 Univ Sheffield Anti-helicobacter activity of celery seed components
EP1662906A1 (en) 2003-09-23 2006-06-07 DSM IP Assets B.V. Compositions for the treatment and prevention of diabetes mellitus
CN1257711C (zh) 2003-12-05 2006-05-31 石药集团中奇制药技术（石家庄）有限公司 丁苯酞软胶囊及其制备工艺
ES2375302T3 (es) * 2005-05-24 2012-02-28 Dsm Ip Assets B.V. Derivados de ligustilida para el tratamiento de trastornos inflamatorios.
KR20090078777A (ko) * 2006-08-11 2009-07-20 디에스엠 아이피 어셋츠 비.브이. 중추 신경계 질환의 치료를 위한 리구스틸라이드 유도체
CN100569241C (zh) * 2007-01-17 2009-12-16 北京天川军威医药技术开发有限公司 芹菜籽乙酸乙酯萃取物及其用途
US8722338B2 (en) 2009-03-11 2014-05-13 The Johns Hopkins University Modulation of ABCG2-mediated urate transport to treat hyperuricemia and gout
AU2010329604B2 (en) * 2009-11-23 2016-05-19 Bagi Research Limited Novel therapeutic methods for treating inflammation and immune system disorders
CN102697772A (zh) * 2012-05-08 2012-10-03 中国人民解放军第二军医大学 一种治疗痛风的药物组合物及其应用
CN103183654B (zh) * 2013-01-30 2014-11-05 泰山医学院 芹菜籽活性单体的分离纯化制备工艺
CN105535116A (zh) * 2015-12-23 2016-05-04 辽宁科技学院 一种天然药物提取物及其制备方法
CN110582480B (zh) 2017-04-21 2023-11-10 塔斯马尼亚大学 治疗化合物和方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2334368A1 (fr) * 1975-12-10 1977-07-08 Unilever Nv Procede d'isolation, a partir des pepins de raisin, d'une substance a activite anti-inflammatoire, et composition pour la peau, contenant une telle substance
DE3040246C2 (de) * 1979-10-29 1985-01-10 Osaka Chemical Laboratory Co., Ltd., Osaka Sojasaponine A↓1↓ und A↓2↓ und ihre Verwendung
DE3347658A1 (de) * 1983-12-31 1985-07-11 Troponwerke GmbH & Co KG, 5000 Köln 1.4-naphthochinonderivate mit entzuendungshemmender wirkung
JPS61257155A (ja) * 1985-05-10 1986-11-14 Horiuchi:Kk 抗酸化食品
JPS63501288A (ja) * 1985-09-20 1988-05-19 ジ・アップジョン・カンパニ− １，４−ナフタレンジオ−ルおよび１，４−ヒドロキノン誘導体
US4753935A (en) * 1987-01-30 1988-06-28 Syntex (U.S.A.) Inc. Morpholinoethylesters of mycophenolic acid and pharmaceutical compositions
FR2611502B1 (fr) * 1987-02-24 1990-03-09 Natura Medica Laboratoires Extrait de racines d'ombellifere obtenu par extraction hydroalcoolique, procede de preparation d'un tel extrait; et composition therapeutique, notamment a activite diuretique, cardiovasculaire, antalgique ou anti-inflammatoire comprenant un tel extrait
JPH02196767A (ja) * 1988-10-11 1990-08-03 Kyowa Hakko Kogyo Co Ltd ヒドロキサム酸誘導体
US5102883A (en) * 1989-10-31 1992-04-07 Du Pont Merck Pharmaceutical Company Pyrimidine biosynthesis inhibitors useful as immunosuppressive agents
IT1242020B (it) * 1990-11-20 1994-02-02 Sigma Tau Ind Farmaceuti Ftalidilidene derivati della carnitina e di alcanoil carnitine e composizioni farmaceutiche che li contengono.
AU653024B2 (en) * 1991-05-30 1994-09-15 Novartis Ag Substituted diaminophthalimides and analogues

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006528666A (ja) * 2003-05-14 2006-12-21 ディーエスエム アイピー アセッツ ビー．ブイ． 糖尿病の治療及び予防のためのフタリド誘導体の使用
JP2012006923A (ja) * 2003-05-14 2012-01-12 Dsm Ip Assets Bv 糖尿病の治療及び予防のためのフタリド誘導体の使用
JP2011256121A (ja) * 2010-06-07 2011-12-22 Kao Corp 電位依存性カチオンチャネル抑制剤
WO2021221456A1 (ko) * 2020-04-29 2021-11-04 한국 한의학 연구원 시라 추출물을 유효성분으로 함유하는 골질환의 예방, 개선 또는 치료용 조성물

Also Published As

Publication number Publication date
ZA944568B (en) 1995-03-20
DE69421280T2 (de) 2000-07-13
IN178310B (https=) 1997-03-22
PL312714A1 (en) 1996-05-13
PL176595B1 (pl) 1999-06-30
EP0708651A1 (en) 1996-05-01
ATE185698T1 (de) 1999-11-15
NZ267567A (en) 1997-10-24
CN1129908A (zh) 1996-08-28
DE69421280D1 (de) 1999-11-25
EP0708651A4 (en) 1998-03-04
WO1995000157A1 (en) 1995-01-05
CA2165794A1 (en) 1995-01-05
EP0708651B1 (en) 1999-10-20
ES2140541T3 (es) 2000-03-01

Similar Documents

Publication Publication Date Title
JPH09505024A (ja) 治療剤
AU2002332464B2 (en) Nutritional supplements and methods of using same
JP3048642B2 (ja) ウコンの無極性および極性抽出物の取得方法およびその用途
DE69837551T2 (de) Zusammensetzung und verfahren zur behandlung der alzheimer'schen krankheit und anderen amyloidosen
DE69532469T2 (de) Adhäsion inhibierender Vaccinium Extrakt
JP4125367B2 (ja) 中国薬草抽出物
US7956067B2 (en) Composition comprising at least one higher aliphatic alcohol and an extract of Griffonia simplicifolia
AU2002332464A1 (en) Nutritional supplements and methods of using same
JP5684124B2 (ja) ベタレイン組成物およびそれらの使用
JP6410355B2 (ja) 疾患を治療するための新規の方法及び組成物
JP2009521407A (ja) モリンダ・シトリフォリア葉汁および葉抽出物をベースとする製剤
EP0075523B1 (fr) Nouveaux médicaments à base d'extraits d'algues, et formulations correspondantes
DE60206270T2 (de) Zusammensetzungen enthaltend thylakoids zur modulierung der entzündung
WO2023286977A1 (ko) 수용화 매스틱 검 또는 감태나무 추출물을 이용한 항알러지용 조성물
HUE028681T2 (en) Amorphous crystalline structure containing a dehydrated fermented material
EP2397136A1 (fr) Composition anti-inflammatoire
Al-Snafi The efficacy and safety of medicinal plants documented by clinical trials (part 1)
Zehra et al. Evaluation of anti-urolithiatic potential of leaves of Alstonia scholaris and its isolated pentacyclic triterpenoids in ethylene glycol-induced renal calculi rat model
CN1189156C (zh) 皮肤增白剂
US12496267B2 (en) Extract of organic humified materials
AU691815B2 (en) Therapeutic agent
JP7719641B2 (ja) 便中脂質排泄促進剤
JPH1072361A (ja) 茶葉抽出物のｔｎｆ産生抑制剤
KR20250138311A (ko) 새싹보리 초음파 추출물을 유효성분으로 함유하는 혈행 개선 또는 항염증용 조성물
WO2003084554A1 (de) Weidenextrakt